# Adnexus Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adnexus-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Waltham, US
- Website: www.adnexustx.com
- Total disclosed funding: $48M
- Latest round: Series C (Aug 9, 2007)
- Investors on record: 5

## About

Adnexus is a US based pharmaceutical company, engaged in the discovery and development of Adnectins™, a proprietary type of targeted biologic. Adnectins are proteins designed to either block or stimulate therapeutic targets of interest to help fight diseases across a broad range of therapeutic areas.

## Funding rounds

- Series C, Aug 9, 2007, $16M — Atlas Venture, Flagship Pioneering, Polaris Partners, HBM Partners, Venrock
- Series B, Jun 14, 2006, $17M — Atlas Venture, Flagship Pioneering, Polaris Partners, Venrock
- Series A, Jan 18, 2005, $16M — Atlas Venture, Flagship Pioneering, Polaris Partners

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A, Series B, Series C
- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Series A, Series B, Series C
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A, Series B, Series C
- Venrock (https://capitalatlas.ai/funds/venrock) — Series B, Series C
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series C